Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...

A rapid test harnessing the power of AI is set to transform the diagnosis of a lung condition that affects 3 million people ...

Lilavati Hospital Marks the Successful End of India’s First 'Nursing Excellence Training Program' in Collaboration with Mayo ...

Dr. Jad Kebbe, a pulmonologist at the University of Oklahoma Health Sciences Center, discusses the risks of inhaling wildfire ...

Q4 2024 Earnings Call Transcript March 27, 2025 P3 Health Partners Inc. misses on earnings expectations. Reported EPS is ...